Literature DB >> 9150358

Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms.

D Watters1, K K Khanna, H Beamish, G Birrell, K Spring, P Kedar, M Gatei, D Stenzel, K Hobson, S Kozlov, N Zhang, A Farrell, J Ramsay, R Gatti, M Lavin.   

Abstract

The recently cloned gene (ATM) mutated in the human genetic disorder ataxia-telangiectasia (A-T) is involved in DNA damage response at different cell cycle checkpoints and also appears to have a wider role in signal transduction. Antibodies prepared against peptides from the predicted protein sequence detected a approximately 350 kDa protein corresponding to the open reading frame, which was absent in 13/23 A-T homozygotes. Subcellular fractionation, immunoelectronmicroscopy and immunofluorescence showed that the ATM protein is present in the nucleus and cytoplasmic vesicles. This distribution did not change after irradiation. We also provide evidence that ATM protein binds to p53 and this association is defective in A-T cells compatible with the defective p53 response in these cells. These results provide further support for a role for the ATM protein as a sensor of DNA damage and in a more general role in cell signalling, compatible with the broader phenotype of the syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150358     DOI: 10.1038/sj.onc.1201037

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM.

Authors:  G C Smith; R B Cary; N D Lakin; B C Hann; S H Teo; D J Chen; S P Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  ATM protein synthesis patterns in sporadic breast cancer.

Authors:  R Kairouz; R A Clarke; P J Marr; D Watters; M F Lavin; J H Kearsley; C S Lee
Journal:  Mol Pathol       Date:  1999-10

3.  The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells.

Authors:  E Fritz; A A Friedl; R M Zwacka; F Eckardt-Schupp; M S Meyn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

4.  Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.

Authors:  N Zhang; P Chen; K K Khanna; S Scott; M Gatei; S Kozlov; D Watters; K Spring; T Yen; M F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 5.  Radiological imaging in ataxia telangiectasia: a review.

Authors:  Ishani Sahama; Kate Sinclair; Kerstin Pannek; Martin Lavin; Stephen Rose
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

6.  ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation.

Authors:  C Barlow; C Ribaut-Barassin; T A Zwingman; A J Pope; K D Brown; J W Owens; D Larson; E A Harrington; A M Haeberle; J Mariani; M Eckhaus; K Herrup; Y Bailly; A Wynshaw-Boris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

7.  Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.

Authors:  Shaun P Scott; Regina Bendix; Philip Chen; Raymond Clark; Thilo Dork; Martin F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

8.  Regulation of hyphal morphogenesis and the DNA damage response by the Aspergillus nidulans ATM homolog AtmA.

Authors:  Iran Malavazi; Camile P Semighini; Marcia Regina von Zeska Kress; Steven D Harris; Gustavo H Goldman
Journal:  Genetics       Date:  2006-01-16       Impact factor: 4.562

9.  Cleavage and inactivation of ATM during apoptosis.

Authors:  G C Smith; F d'Adda di Fagagna; N D Lakin; S P Jackson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

10.  ATM binds to beta-adaptin in cytoplasmic vesicles.

Authors:  D S Lim; D G Kirsch; C E Canman; J H Ahn; Y Ziv; L S Newman; R B Darnell; Y Shiloh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.